We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Swimming Nanobots Designed to Deliver Drugs

By LabMedica International staff writers
Posted on 20 Aug 2012
When an object is only a few microns long, swimming can be difficult as the viscosity of water is more similar to that of honey, and momentum cannot be relied upon to propel them forward. More...
Microorganisms, of course, have evolved ways to swim in spite of these hurdles; however, tiny robots have not quite progressed to this stage. Now a team of researchers has used complicated computational models to devise swimming micro-robots that could overcome these challenges to carry cargo and navigate in response to stimuli such as light.

When they are actually built, these simple micro-swimmers could rely on volume alterations in novel substances known as hydrogels to move tiny flaps that will propel the robots. The micro-devices could be used in drug delivery, lab-on-a-chip microfluidic systems--and even as micro-construction robots working in swarms.

The simple micro-swimmers were described July 23, 2012, in the online advance edition of the journal Soft Matter, published by the UK Royal Society of Chemistry. “We believe that our simulations will give experimentalists a reason to pursue development of these micro-swimmers to go beyond what is available now,” said Dr. Alexander Alexeev, an assistant professor in the George W. Woodruff School of Mechanical Engineering at Georgia Institute of Technology. “We wanted to demonstrate the principle of how robots this small could move by determining what is important and what would need to be used to build a real system.”

The simple swimmer developed by Dr. Alexeev and collaborators Hassan Masoud and Benjamin Bingham consists of a responsive gel body approximately 10-micrometers-long with two propulsive flaps attached to opposite sides. A steering flap sensitive to specific stimuli would be located at the front of the swimmer. The responsive gel body would undergo periodic expansions and contractions triggered by oscillatory chemical reactions, oscillating magnetic or electric fields, or by cycles of temperature change. These expansions and contractions--the chemical swelling and de-swelling of the substance--would create a beating motion in the stiff propulsive flaps attached to each side of the micro-swimmer. Combined with the movement of the gel body, the beating motion would move the micro-swimmer forward.

The trajectory of the micro-swimmer would be controlled by a flexible steering flap on its front. The flap would be made of a substance that deforms based on changes in light intensity, temperature, or magnetic field. “The combination of these flaps and the oscillating body creates a very nice motion that we believe can be used to propel the swimmer,” said Dr. Alexeev. “To build a device that is autonomous and self-propelling at the micron-scale, we cannot build a tiny submarine. We have to keep it simple.”

Crucial to the operation of the micro-swimmer would be the latest generation of hydrogels, compounds whose volume changes in a cyclical way. The hydrogels would serve as “chemical engines” to provide the motion needed to move the device’s propulsive flaps. Such materials currently exist and are being improved upon for other applications. “We are using the state-of-the art in materials science, changing the properties of the material,” explained Mr. Masoud, a PhD candidate in the School of Mechanical Engineering. “We have combined the materials with the principles of hydrodynamics at the small scale to develop this new swimmer.”

As part of their modeling, the researchers examined the effects of flaps of different sizes and characteristics. They also researched how flexible the micro-swimmer’s body needed to be to produce the kind of movement required for swimming. “You can’t swim at the small scale in the same way you swim at the large scale,” Dr. Alexeev said. “There is no inertia, which is how you keep moving at the large scale. What happens at the small scale is counterintuitive to what you expect at the large scale.”

The computational fluid modeling the researchers used allowed them to study a wide range of parameters in materials, oscillation rates, and flexibility. What they found, Dr. Alexeev said, would give experimentalists a starting point for actually building prototypes of the flexible gel robots. “We have captured the solid mechanics of the periodically-oscillating body, the fluid dynamics of moving through the viscous liquid, and the coupling between the two,” he said. “From a computational fluid dynamics standpoint, it’s not an easy problem to model at this scale.”

Eventually, the researchers hope to work with an experimental team to construct the microswimmers. Combining their theoretic work with actual research could be a formidable approach to building robots on this size scale. “This is a simulation that we hope to see in real life one day,” Dr. Alexeev said. “We have learned how experimentalists can pursue fabrication of these devices without extensive trial-and-error. We can use the simulations to look inside what will happen by using the laws of physics to explain it.”

The researchers foresee groups of micro-swimmers carrying cargo through microfluidic chips or other devices. Hordes of them could one day work together as tiny construction robots moving materials to desired locations for assembly. But the micro-swimmers will not win any Olympic competitions. Dr. Alexeev estimates that their top speed could be on the order of a few micrometers per second--which should be enough to accomplish their mission. “If your body is micrometers in size, that kind of speed is really not too bad,” he concluded. “The swimming speed will be rather slow, but at that size scale, you don’t really need to go very fast since you only need to go short distances.”

Related Links:

Georgia Institute of Technology



New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Modular Hemostasis Automation Solution
CN Track
New
Staining Management Software
DakoLink
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.